These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8128835)

  • 1. Tetrahydroaminoacridine (THA) in Alzheimer's disease: an assessment of attentional and mnemonic function using CANTAB.
    Sahakian BJ; Coull JT
    Acta Neurol Scand Suppl; 1993; 149():29-35. PubMed ID: 8128835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further analysis of the cognitive effects of tetrahydroaminoacridine (THA) in Alzheimer's disease: assessment of attentional and mnemonic function using CANTAB.
    Sahakian BJ; Owen AM; Morant NJ; Eagger SA; Boddington S; Crayton L; Crockford HA; Crooks M; Hill K; Levy R
    Psychopharmacology (Berl); 1993; 110(4):395-401. PubMed ID: 7870908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Physostigmine and tetrahydroaminoacridine treatment of Alzheimer's disease.
    Gustafson L
    Acta Neurol Scand Suppl; 1993; 149(Rand):39-41. PubMed ID: 8128836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrine (tetrahydroaminoacridine; THA) and lecithin in senile dementia of the Alzheimer type: a multicentre trial. Groupe Français d'Etude de la Tetrahydroaminoacridine.
    Chatellier G; Lacomblez L
    BMJ; 1990 Feb; 300(6723):495-9. PubMed ID: 2107926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrine in Alzheimer's disease.
    Eagger SA; Levy R; Sahakian BJ
    Lancet; 1991 Apr; 337(8748):989-92. PubMed ID: 1673209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group.
    Davis KL; Thal LJ; Gamzu ER; Davis CS; Woolson RF; Gracon SI; Drachman DA; Schneider LS; Whitehouse PJ; Hoover TM
    N Engl J Med; 1992 Oct; 327(18):1253-9. PubMed ID: 1406817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frontal dysfunction blocks the therapeutic effect of THA on attention in Alzheimer's disease.
    Riekkinen P; Riekkinen M; Soininen H; Kuikka J; Laakso M; Riekkinen P
    Neuroreport; 1997 May; 8(8):1845-9. PubMed ID: 9223063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute nicotine administration on cognitive event-related potentials in tacrine-treated and non-treated patients with Alzheimer's disease.
    Knott V; Mohr E; Mahoney C; Engeland C; Ilivitsky V
    Neuropsychobiology; 2002; 45(3):156-60. PubMed ID: 11979067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychometric discrimination of tetrahydroaminoacridine responders in Alzheimer patients.
    Alhainen K; Helkala EL; Riekkinen P
    Dementia; 1993; 4(1):54-8. PubMed ID: 8358507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of cholinergic drug effects on memory in Alzheimer's disease.
    Brinkman SD; Gershon S
    Neurobiol Aging; 1983; 4(2):139-45. PubMed ID: 6355883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discrimination of Alzheimer patients responding to cholinesterase inhibitor therapy.
    Alhainen K; Riekkinen PJ
    Acta Neurol Scand Suppl; 1993; 149():16-21. PubMed ID: 7907454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of tacrine and lecithin in mild to moderate Alzheimer's disease: double blind trial.
    Maltby N; Broe GA; Creasey H; Jorm AF; Christensen H; Brooks WS
    BMJ; 1994 Apr; 308(6933):879-83. PubMed ID: 8173365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA.
    Mohammed AH
    Acta Neurol Scand Suppl; 1993; 149():13-5. PubMed ID: 8128832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute nicotine effects on auditory sensory memory in tacrine-treated and nontreated patients with Alzheimer's disease: an event-related potential study.
    Engeland C; Mahoney C; Mohr E; Ilivitsky V; Knott VJ
    Pharmacol Biochem Behav; 2002 May; 72(1-2):457-64. PubMed ID: 11900820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial.
    Jenike MA; Albert MS; Heller H; Gunther J; Goff D
    J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responder characteristics to a single oral dose of cholinesterase inhibitor: a double-blind placebo-controlled study with tacrine in Alzheimer patients.
    Almkvist O; Jelic V; Amberla K; Hellström-Lindahl E; Meurling L; Nordberg A
    Dement Geriatr Cogn Disord; 2001; 12(1):22-32. PubMed ID: 11125238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease.
    Jones GM; Sahakian BJ; Levy R; Warburton DM; Gray JA
    Psychopharmacology (Berl); 1992; 108(4):485-94. PubMed ID: 1410164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WITHDRAWN: Tacrine for Alzheimer's disease.
    Qizilbash N; Birks J; Lopez Arrieta J; Lewington S; Szeto S
    Cochrane Database Syst Rev; 2007 Jul; (3):CD000202. PubMed ID: 17636619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hippocampal atrophy, acute THA treatment and memory in Alzheimer's disease.
    Riekkinen P; Soininen H; Helkala EL; Partanen K; Laakso M; Vanhanen M; Riekkinen P
    Neuroreport; 1995 Jun; 6(9):1297-300. PubMed ID: 7669991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotine and sensory memory in Alzheimer's disease: an event-related potential study.
    Engeland C; Mahoney C; Mohr E; Ilivitsky V; Knott V
    Brain Cogn; 2002 Jul; 49(2):232-4. PubMed ID: 15259398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.